Formulation of 99mTc-Radiopharmaceutical Kits
| Radiopharmaceutical | Kit | Ingredients | Reconstitution | |
| 99mTc-butedronate | Teceos (CIS Bio) | 13 mg of 3,3 diphospho-1,2-propanedicarboxylic acid, tetrasodium salt (butedronate), SnCl2⋅2H2O, N-(4-aminobenzoyl)-l-glutamic acid | 99mTc-TcO4− | 2–10 mL, 0.4–11.1 GBq (10–300 mCi), 5 min of shaking, room temperature |
| Butedronate | 1.3–6.5 mg/mL | |||
| 99mTc-oxidronate | Technescan oxidronate (Mallinckrodt) | 3 mg of disodium-oxidronate, SnCl2⋅2H2O, gentisinic acid, sodium chloride | 99mTc-TcO4− | 3–10 mL, 1.5–11.1 GBq (40–300 mCi), 0.5 min of shaking, room temperature |
| Oxidronate | 0.3–1.0 mg/mL | |||
| 99mTc-medronate | Medronate Tc-IK-10 (Izotop) | 5 mg of medronic acid (medronate), SnCl2⋅2H2O, ascorbic acid, urea | 99mTc-TcO4− | 2–5 mL, 3–6 GBq (80–160 mCi), 15 min of incubation, room temperature |
| Medronate | 1–2.5 mg/mL | |||
| 99mTc-tetrofosmin | Myoview (GE Healthcare) | 0.23 mg of tetrofosmin, SnCl2⋅2H2O, disodium sulphosalicylate, sodium d-gluconate, sodium hydrogen carbonate | 99mTc-TcO4− | 4–8 mL, <8.8 GBq (<240 mCi), 15 min of incubation, room temperature |
| Tetrofosmin | 0.03–0.06 mg/mL | |||
| 99mTc-sestamibi | Stamicis (CIS Bio) | 1 mg of tetrakis (2-methoxyisobutyl isonitrile) copper (I) tetrafluoroborate, SnCl2⋅2H2O, cysteine hydrochloride monohydrate, sodium citrate, mannitol | 99mTc-TcO4− | 1–3 mL, 0.2–11 GBq (5–290 mCi), 10 min of incubation, 100°C |
| Sestamibi | 0.33–1 mg/mL | |||
| 99mTc-DMSA (99mTc-succimer) | Renocis (CIS Bio) | 1 mg of dimercaptosuccinic acid, SnCl2⋅2H2O, ascorbic acid, inositol | 99mTc-TcO4− | 1–6 mL, <3.7 GBq (<100 mCi), 5–10 min of shaking, room temperature |
| DMSA | 0.17–1 mg/mL |